BEAT...$1.00...🥳...Upper Bollie Break...
georgie18
Re: georgie18 post# 396
Friday, April 17, 2026 10:39:59 AM
Post#
397
of 398
BEAT...99...🥳...Filling the open gap here...
georgie18
Re: georgie18 post# 395
Friday, April 17, 2026 9:43:10 AM
Post#
396
of 396
BEAT...9630...🥳
georgie18
Re: georgie18 post# 393
Friday, April 17, 2026 8:36:53 AM
Post#
395
of 395
BEAT...89s clearing here...🥳...bought the .80 range offering dip...
georgie18
Re: US Market News post# 392
Wednesday, April 15, 2026 8:45:37 AM
Post#
393
of 394
BEAT...88...🥳...Buying Dips on offering... HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock
April 14, 2026 10:00 PM
Business Wire
Offering is being led by HeartBeam’s first commercial customer, ClearCardio™, the Company's executive leadership, board members, and existing investors
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the pricing of its underwritten public offering of 12,500,000 shares of its common stock for total gross proceeds of $10 million, before deducting underwriting discounts, commissions, and offering expenses. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 1,875,000 shares to cover over-allotments, if any, at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about April 16, 2026, subject to customary closing conditions.
The offering is being led by HeartBeam’s first commercial customer, ClearCardio™, the Company's executive leadership, board members, existing investors, and several fundamental institutional investors.
georgie18
Re: georgie18 post# 396
Friday, April 17, 2026 10:39:59 AM
Post#
397
of 398
BEAT...99...🥳...Filling the open gap here...
georgie18
Re: georgie18 post# 395
Friday, April 17, 2026 9:43:10 AM
Post#
396
of 396
BEAT...9630...🥳
georgie18
Re: georgie18 post# 393
Friday, April 17, 2026 8:36:53 AM
Post#
395
of 395
BEAT...89s clearing here...🥳...bought the .80 range offering dip...
georgie18
Re: US Market News post# 392
Wednesday, April 15, 2026 8:45:37 AM
Post#
393
of 394
BEAT...88...🥳...Buying Dips on offering... HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock
April 14, 2026 10:00 PM
Business Wire
Offering is being led by HeartBeam’s first commercial customer, ClearCardio™, the Company's executive leadership, board members, and existing investors
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the pricing of its underwritten public offering of 12,500,000 shares of its common stock for total gross proceeds of $10 million, before deducting underwriting discounts, commissions, and offering expenses. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 1,875,000 shares to cover over-allotments, if any, at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about April 16, 2026, subject to customary closing conditions.
The offering is being led by HeartBeam’s first commercial customer, ClearCardio™, the Company's executive leadership, board members, existing investors, and several fundamental institutional investors.
Recent BEAT News
- HeartBeam Reports First Quarter 2026 Results • Business Wire • 05/13/2026 08:01:00 PM
- HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic • Business Wire • 05/11/2026 12:31:00 PM
- HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice • Business Wire • 05/07/2026 12:31:00 PM
- HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time • Business Wire • 04/30/2026 12:31:00 PM
- HeartBeam Announces Closing of $10 Million Public Offering of Common Stock • Business Wire • 04/16/2026 08:05:00 PM
- HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock • Business Wire • 04/15/2026 02:00:00 AM
- HeartBeam Announces Proposed Public Offering of Common Stock • Business Wire • 04/14/2026 08:05:00 PM
- How Decentralized AI is Unlocking Value in Cardiac Diagnostics • PR Newswire (Canada) • 03/27/2026 01:30:00 PM
- How Decentralized AI is Unlocking Value in Cardiac Diagnostics • PR Newswire (US) • 03/27/2026 01:30:00 PM
- HeartBeam Reports Fourth Quarter and Full Year 2025 Results • Business Wire • 03/12/2026 08:01:00 PM
- HeartBeam Partners With Mount Sinai to Advance AI-Powered ECG Technology • IH Market News • 03/10/2026 02:41:12 PM
- HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home • Business Wire • 03/10/2026 11:00:00 AM
- HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch • Business Wire • 03/09/2026 11:00:00 AM
- HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study • Business Wire • 03/05/2026 12:00:00 PM
- HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time • Business Wire • 03/04/2026 09:01:00 PM
- HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market • Business Wire • 03/04/2026 12:00:00 PM
- HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer • Business Wire • 01/22/2026 12:00:00 PM
- HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference • Business Wire • 01/05/2026 12:00:00 PM
- Credit-Card Sized Device Wins FDA Clearance for At-Home Heart Monitoring • AllPennyStocks.com • 12/10/2025 04:44:00 PM
- HeartBeam Shares Skyrocket After FDA Signs Off on 12-Lead ECG Synthesis Software • IH Market News • 12/10/2025 02:15:00 PM
- HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment • Business Wire • 12/10/2025 12:00:00 PM
- HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application • Business Wire • 11/26/2025 09:32:00 PM
- HeartBeam Reports Third Quarter 2025 Results • Business Wire • 11/13/2025 09:01:00 PM
- HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern Time • Business Wire • 10/30/2025 11:00:00 AM
- HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere • Business Wire • 10/28/2025 11:00:00 AM
